Previous studies were performed on APP/PS1 mice, another model of AD, regarding effect of citalopram [8, 9, 29] and the present study found that the treatment decreased Aβ accumulation in 3xTgAD mouse model for the first time. Here, APP is linked to Alzheimer disease.